Haematologica · 2009 · 30 citations · 11 references
MedicineGeneticsMolecular GeneticsHemostasisHuman GeneticsMedical GeneticsCoagulation AbnormalitiesCoagulation DisordersCoagulation Factor DeficienciesCoagulation PhysiologyHemostasis DisordersHemostatic DisordersBleedingCoagulationCoagulation DysregulationHereditary Bleeding DisordersInherited Coagulation Factor DeficienciesMutationPlatelet Aggregation DefectsRare Bleeding Disorders
We describe a 16-year-old girl and her 41-year-old father who both had a bleeding tendency, dramatic prolongation of all standard clotting assays, undetectable levels of plasma protein C activity, and low or borderline levels of factors X, XI and XII. Plasma and serum electrophoresis revealed a minor peak following the main alpha(1) globulin peak, of which the proportion was increased. Platelet aggregation by thrombin (final concentration 1 U/mL) was absent in both patients, but this inhibition can be overcome by increasing the concentration of thrombin (4 U/mL). The molecular defect responsible for these coagulation abnormalities was identified by genomic sequencing. Both patients are heterozygous for alpha(1)-antitrypsin Met 358 to Arg (alpha(1)-antitrypsin Pittsburgh). Seven other members of this pedigree had normal coagulation tests and do not carry the same genetic mutation. This unique family with alpha1-antitrypsin Pittsburgh sheds some light on the study of this extremely rare mutation and its inheritance.
11
Mutation of Antitrypsin to Antithrombin
Maurice C. Owen, Stephen O. Brennan, Jessica H. Lewis et al. · New England Journal of Medicine · 1983 · 435 citations
Antithrombin Pittsburgh: an alpha1-antitrypsin variant causing hemorrhagic disease
JH Lewis, RM Iammarino, JA Spero et al. · Blood · 1978 · 87 citations · Full text
Medicine, Pathology, Hemostasis +11